Social Worker and Psychotropic Medication Toward Effective Collaboration with Mental Health Clients, Families, and Providers

Name: Social Worker and Psychotropic Medication Toward Effective Collaboration with Mental Health Clients, Families, and Providers
Price: 6.25 USD
Availability: InStock
ISBN: 9780534365424

ISBN-10: 0534365426

ISBN-13: 9780534365424

Edition: 2nd 2001

Authors: Kia J. Bentley, Joseph Walsh

List price: $72.95

30 day, 100% satisfaction guarantee!

Marketplace

2 new & used from $6.25

what's this?

Rush Rewards U
Members Receive:

You have reached 400 XP and carrot coins. That is the daily max!

This book is a practical and useful resource for social work students and practitioners as they fill and expand their daily roles in psychiatric medication management. The authors provide readers with the information they need to be aware, articulate, and active with respect to client's medication-related dilemmas, but also mindful of the sociopolitical context of prescription practice in psychiatry. All the facts, myths, and relevant information about psychotropic medication are presented to social workers in an easy-to-access manner. Professionals and students alike will find this book to be a practical resource that helps them to be more responsive to the medication-related concerns of…

Book details

List price: $72.95
Edition: 2nd
Copyright year: 2001
Publisher: Wadsworth
Publication date: 8/2/2000
Binding: Paperback
Pages: 328
Size: 6.00" wide x 9.00" long x 0.75" tall
Weight: 1.100
Language: English

Dr. Kia J. Bentley is a licensed clinical social worker, tenured professor, and Director of the Ph.D. Program in Social Work at Virginia Commonwealth University, where she has taught since 1989. Her current teaching focuses on mental health and mental illness, psychopharmacotherapy and social work, clinical theory, and research. She is consulting editor for The Journal of Social Work Education and chapter member of the editorial board of Best Practices in Mental Health. In Virginia, she is the chair of the Human Rights Committee of Central State Hospital. She is the author of another Cengage Brooks/Cole text, SOCIAL WORK PRACTICE IN MENTAL HEALTH: CONTEMPORARY ROLES, TASKS, AND TECHNIQUES…

Joseph Walsh received his MSW and his Ph.D. from Ohio State University. He is Associate Professor of Social Work at Virginia Commonwealth University and teaches courses in generalist practice, clinical practice, research, and mental and emotional disorders. He has been a direct services practitioner in the field of mental health since 1974, first in a psychiatric hospital and later in community mental health center settings. Joe has provided services to older adult and general outpatient populations, but he specializes in services to people with serious mental illness and their families. He is the author of two other Brooks/Cole texts, CLINICAL CASE MANAGEMENT WITH PERSONS HAVING MENTAL…

Preface	p. xiii
Social Work Roles in Medication Management	p. 1
History and Overview of Social Work Roles in Medication Management	p. 3
Introduction	p. 3
Five Case Scenarios	p. 3
The Changing Roles of Social Workers	p. 7
A Historical Context of Intervention for People with Mental Illness	p. 10
The Treatment of People with Mental Illness Prior to 1950	p. 10
The Rise of Psychiatric Social Work	p. 11
The Introduction of Psychotropic Medications	p. 12
Social Work Role Categories	p. 14
Physician's Assistant	p. 14
Consultant	p. 14
Counselor	p. 15
Monitor	p. 16
Advocate	p. 17
Educator	p. 19
Researcher	p. 20
Social Worker Roles and Professional Values	p. 20
Summary	p. 21
Defining Effective Collaboration	p. 24
Principles of a Partnership Model of Practice	p. 24
Appreciate Participants' Strengths and Limits	p. 25
Embrace Client-Centered Practice	p. 26
Reconceptualize the Client-Clinician Relationship	p. 27
Conceptualize the Role of the Social Worker as a Resource	p. 28
Appreciate the Family Member's Perspective	p. 29
Maintaining a Balanced Perspective	p. 30
Rights of Individual, Family, and Society	p. 31
Costs Versus Benefits of Medications	p. 32
Expanded Roles with Regard to Related Professions	p. 33
Integrating Psychosocial Interventions and Psychopharmacology	p. 35
Competing Ideologies	p. 35
Managing Parallel Treatment	p. 36
Summary	p. 39
A Primer on Psychopharmacology	p. 41
Basic Principles: Neurotransmission, Pharmacokinetics, and Pharmacodynamics	p. 43
The Central Nervous System	p. 44
The Brain and Nervous System	p. 44
Properties of Nerve Cells	p. 49
Neuron Structure	p. 49
Neuron Function	p. 51
Neurotransmitters	p. 52
Acetylcholine	p. 53
Norepinephrine	p. 53
Dopamine	p. 53
Serotonin	p. 54
Gamma Aminobutyric Acid (GABA)	p. 54
Glutamate (Glutamic Acid)	p. 54
How a Drug Moves Through the Body	p. 55
Absorption	p. 55
Distribution	p. 55
Metabolism	p. 56
Excretion	p. 57
The Effects of a Drug on the Body	p. 58
Five Classes of Psychotropic Medication	p. 60
Antipsychotic Medications	p. 60
Antidepressant Medications	p. 61
Mood-Stabilizing Drugs	p. 63
Anti-Anxiety Medications	p. 64
Psychostimulants	p. 65
Adverse Effects of Psychotropic Medication	p. 66
Adverse Physical Effects: Definition	p. 67
Adverse Physical Effects: Factors in Their Production	p. 68
Adverse Psychological Effects	p. 69
Adverse Social Effects	p. 69
Summary	p. 70
Specific Medications for Specific Disorders	p. 71
Antipsychotic Medications	p. 72
Symptoms of Psychotic Disorders	p. 72
Specific Medications	p. 75
Origins	p. 75
Current Medications	p. 76
Conventional Antipsychotics	p. 79
Adjunctive and Side-Effect Medications	p. 81
The Newer Antipsychotics	p. 82
Case Examples	p. 84
Antidepressant Medications	p. 87
Symtoms of Mood Disorders	p. 88
Specific Medications	p. 89
Origins	p. 89
Current Medications	p. 90
Antidepressant Medications and Relapse Prevention	p. 91
The MAO Inhibitors	p. 92
Cyclic Antidepressants	p. 94
The Serotonin Reuptake Inhibitors and Other New Drugs	p. 97
Recent Advances in the Drug Treatment of Depression	p. 98
Case Examples	p. 99
Mood-Stabilizing Medications	p. 101
Symptoms of Mania	p. 102
Specific Medications	p. 103
Origins	p. 103
Current Medications	p. 104
Lithium for Relapse Prevention	p. 108
The Anticonvulsant Medications	p. 109
Anticonvulsants for Relapse Prevention	p. 112
Medications Under Investigation	p. 112
Case Examples	p. 113
Anti-Anxiety Medications	p. 116
Symptoms of Anxiety Disorders	p. 116
Specific Medications	p. 119
Origins	p. 119
Current Medications	p. 120
The Benzodiazepines	p. 120
Buspirone	p. 123
Other Anti-Anxiety Medications	p. 124
Special Concerns with Children and Adolescents	p. 125
Case Examples	p. 126
Psychostimulants	p. 128
Attention Deficit Hyperactivity Disorder	p. 129
Ethical Issues in the Drug Treatment of Children	p. 129
Specific Medications	p. 131
Origins	p. 131
Current Medications	p. 132
Other Drugs Used to Treat ADHD	p. 134
Case Examples	p. 135
Summary	p. 139
Intervention Concerns with Special Populations	p. 140
Gender Differences	p. 140
General Considerations	p. 140
Neurotransmitters	p. 141
Absorption	p. 142
Distribution	p. 142
Metabolism	p. 142
Classes of Medication	p. 143
Pregnancy	p. 144
Classes of Medication	p. 145
Other Gender-Related Concerns	p. 146
Older Adults	p. 146
General Considerations	p. 146
Classes of Medication	p. 148
Children and Adolescents	p. 150
General Considerations	p. 150
Classes of Medication	p. 152
Racial and Ethnic Differences	p. 154
African Americans	p. 155
Persons of Hispanic Culture	p. 157
Asian Americans	p. 157
Persons with Dual Diagnosis of Mental Illness and Substance Abuse	p. 158
Mental Illness and Alcohol Abuse	p. 160
Summary	p. 161
Knowledge and Skills for Psychosocial Interventions	p. 163
Medication Education for Clients and Families	p. 165
Rationale for Medication Education Issues in Implementing and Evaluating	p. 165
Medication Education	p. 170
Content of Medication Education Programs	p. 175
Summary	p. 180
Medication Adherence and Refusal	p. 181
Models for Understanding Adherence	p. 183
Characteristics of the Client	p. 184
Aspects of Treatment	p. 186
Aspects of the Social Environment	p. 189
Aspects of the Illness or Symptoms	p. 190
Legal and Ethical Issues in Adherence and Refusal	p. 191
Interventions to Assist in Medication Adherence	p. 196
Summary	p. 199
Medication Monitoring and Management	p. 200
Client Self-Monitoring of Medication	p. 202
Using Existing Measures to Guide Monitoring	p. 205
Concrete Steps for Coping with Side Effects	p. 208
Decision Making and Problem Solving in Medication Management	p. 212
Negotiating Medication Issues with Health Care Providers	p. 216
Advocacy in Medication Management	p. 220
Summary	p. 223
Future Directions	p. 225
Future Directions in Psychopharmacology: Implications for Social Workers	p. 227
New Pharmaceutical Treatments	p. 227
The Emergence of Herbal and Vitamin Treatments	p. 230
Herbs	p. 231
Vitamins	p. 232
Expanding Prescription-Writing Privileges	p. 234
Increased Public Scrutiny of Psychotropic Medications	p. 236
Final Words	p. 240
References	p. 241
Alphabetical Listing of Currently Available Prescriptions Described in This Book	p. 267
Glossary	p. 271
Name Index	p. 289
Subject Index	p. 295
Table of Contents provided by Syndetics. All Rights Reserved.